Fréderic Ausseil

1.4k total citations
30 papers, 1.1k citations indexed

About

Fréderic Ausseil is a scholar working on Molecular Biology, Organic Chemistry and Biochemistry. According to data from OpenAlex, Fréderic Ausseil has authored 30 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 5 papers in Organic Chemistry and 4 papers in Biochemistry. Recurrent topics in Fréderic Ausseil's work include Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (6 papers) and Natural product bioactivities and synthesis (5 papers). Fréderic Ausseil is often cited by papers focused on Epigenetics and DNA Methylation (10 papers), Cancer-related gene regulation (6 papers) and Natural product bioactivities and synthesis (5 papers). Fréderic Ausseil collaborates with scholars based in France, Germany and Slovakia. Fréderic Ausseil's co-authors include Isabelle Dufau, Paola B. Arimondo, Christina Gros, Georges Massiot, Jean‐Marc Grégoire, Stéphane Vispé, Alexandre Erdmann, Bruno David, Ludovic Halby and Jacques Fahy and has published in prestigious journals such as Nucleic Acids Research, Journal of Biological Chemistry and PLoS ONE.

In The Last Decade

Fréderic Ausseil

30 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Fréderic Ausseil France 18 753 149 145 126 80 30 1.1k
Kaori Honda Japan 18 708 0.9× 131 0.9× 141 1.0× 149 1.2× 77 1.0× 47 1.0k
Jeong‐Heon Ko South Korea 20 1.1k 1.5× 208 1.4× 153 1.1× 74 0.6× 136 1.7× 41 1.6k
Anthoula Gaigneaux Luxembourg 21 596 0.8× 165 1.1× 119 0.8× 85 0.7× 42 0.5× 40 1.1k
ŞERBAN COMŞA Romania 7 379 0.5× 130 0.9× 245 1.7× 110 0.9× 58 0.7× 13 854
Yongliang Yang China 23 885 1.2× 191 1.3× 254 1.8× 122 1.0× 29 0.4× 64 1.4k
Christian K. Engel Germany 14 1.0k 1.4× 156 1.0× 163 1.1× 65 0.5× 52 0.7× 17 1.3k
Thomas Grombacher Germany 12 910 1.2× 163 1.1× 276 1.9× 63 0.5× 40 0.5× 21 1.2k
Yunyi Wei United States 17 885 1.2× 41 0.3× 123 0.8× 160 1.3× 72 0.9× 31 1.7k
Juan Manuel Domı́nguez Spain 16 556 0.7× 72 0.5× 90 0.6× 148 1.2× 101 1.3× 39 963
Mark Sutherland United Kingdom 19 581 0.8× 53 0.4× 114 0.8× 58 0.5× 75 0.9× 39 943

Countries citing papers authored by Fréderic Ausseil

Since Specialization
Citations

This map shows the geographic impact of Fréderic Ausseil's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Fréderic Ausseil with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Fréderic Ausseil more than expected).

Fields of papers citing papers by Fréderic Ausseil

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Fréderic Ausseil. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Fréderic Ausseil. The network helps show where Fréderic Ausseil may publish in the future.

Co-authorship network of co-authors of Fréderic Ausseil

This figure shows the co-authorship network connecting the top 25 collaborators of Fréderic Ausseil. A scholar is included among the top collaborators of Fréderic Ausseil based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Fréderic Ausseil. Fréderic Ausseil is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
2.
Rodriguez, Frédéric, Dušan Berkeš, Adam Daı̈ch, et al.. (2015). The CERT antagonist HPA-12: First practical synthesis and individual binding evaluation of the four stereoisomers. Bioorganic & Medicinal Chemistry. 23(9). 2004–2009. 19 indexed citations
3.
Faux, Céline, et al.. (2015). Development of a CERT START Domain–Ceramide HTRF Binding Assay and Application to Pharmacological Studies and Screening. SLAS DISCOVERY. 20(6). 779–787. 13 indexed citations
4.
Erdmann, Alexandre, Yoann Menon, Christina Gros, et al.. (2015). Design and synthesis of new non nucleoside inhibitors of DNMT3A. Bioorganic & Medicinal Chemistry. 23(17). 5946–5953. 20 indexed citations
5.
Rotili, Dante, Domenico Tarantino, Biagina Marrocco, et al.. (2014). Properly Substituted Analogues of BIX-01294 Lose Inhibition of G9a Histone Methyltransferase and Gain Selective Anti-DNA Methyltransferase 3A Activity. PLoS ONE. 9(5). e96941–e96941. 30 indexed citations
6.
Erdmann, Alexandre, Christina Gros, Véronique Masson, et al.. (2014). Design, Synthesis and Biological Evaluation of 4‐Amino‐N‐(4‐aminophenyl)benzamide Analogues of Quinoline‐Based SGI‐1027 as Inhibitors of DNA Methylation. ChemMedChem. 9(3). 590–601. 50 indexed citations
7.
Gros, Christina, Virginie Nahoum, Céline Faux, et al.. (2014). New Insights on the Mechanism of Quinoline-based DNA Methyltransferase Inhibitors. Journal of Biological Chemistry. 290(10). 6293–6302. 50 indexed citations
8.
Frongia, Céline, Valérie Lobjois, Arnaud Samson, et al.. (2013). Identification of Chiral Alkenyl‐ and Alkynylcarbinols as Pharmacophores for Potent Cytotoxicity. ChemMedChem. 8(11). 1779–1786. 23 indexed citations
9.
Long, Christophe, Laurence Marcourt, Laure Vendier, et al.. (2013). Dichapetalins from Dichapetalum species and their cytotoxic properties. Phytochemistry. 94. 184–191. 23 indexed citations
10.
11.
Gros, Christina, Jacques Fahy, Ludovic Halby, et al.. (2012). DNA methylation inhibitors in cancer: Recent and future approaches. Biochimie. 94(11). 2280–2296. 177 indexed citations
12.
Long, Christophe, Laurence Marcourt, Fadila Derguini, et al.. (2011). Semisynthetic neoboutomellerone derivatives as ubiquitin-proteasome pathway inhibitors. Bioorganic & Medicinal Chemistry. 20(2). 819–831. 4 indexed citations
13.
Dufau, Isabelle, Anne Lazzari, Arnaud Samson, Isabelle Pouny, & Fréderic Ausseil. (2008). Optimization of a Homogeneous Assay for Kinase Inhibitors in Plant Extracts. Assay and Drug Development Technologies. 6(5). 673–682. 10 indexed citations
14.
Vandenberghe, Isabelle, Laurent Créancier, Stéphane Vispé, et al.. (2008). Physalin B, a novel inhibitor of the ubiquitin-proteasome pathway, triggers NOXA-associated apoptosis. Biochemical Pharmacology. 76(4). 453–462. 55 indexed citations
15.
Fonrose, Xavier, Fréderic Ausseil, Emmanuelle Soleilhac, et al.. (2007). Parthenolide Inhibits Tubulin Carboxypeptidase Activity. Cancer Research. 67(7). 3371–3378. 95 indexed citations
16.
Ausseil, Fréderic, Arnaud Samson, Isabelle Vandenberghe, et al.. (2006). High-Throughput Bioluminescence Screening of Ubiquitin-Proteasome Pathway Inhibitors from Chemical and Natural Sources. SLAS DISCOVERY. 12(1). 106–116. 21 indexed citations
17.
Boudsocq, François, Yvan Canitrot, Martine Knibiehler, et al.. (2005). Modulation of Cellular Response to Cisplatin by a Novel Inhibitor of DNA Polymerase β. Molecular Pharmacology. 67(5). 1485–1492. 43 indexed citations
18.
Massiot, Georges, Christophe Long, Bruno David, et al.. (2005). Acylphloroglucinol Derivatives from Mahurea palustris. Journal of Natural Products. 68(7). 979–984. 7 indexed citations
19.
Debitus, Cécile, et al.. (2004). Heteronemin as a Protein Farnesyl Transferase Inhibitor. Pharmaceutical Biology. 42(6). 454–456. 23 indexed citations
20.
Long, Christophe, et al.. (2003). Bioactive flavonoids of Tanacetum parthenium revisited. Phytochemistry. 64(2). 567–569. 69 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026